st. gallen international consensus on the optimal primary treatment of women with breast cancer
Published 3 years ago • 130 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
3:11
st. gallen consensus 2021: neoadjuvant and adjuvant therapy for her2 breast cancer
-
10:02
the st. gallen consensus session: loco-regional treatment
-
1:07
hereditary breast cancer at st. gallen bcc 2023
-
2:41
key updates from the st gallen consensus session
-
3:10
highlights from the st. gallen consensus panel
-
0:53
st. gallen bcc: reaching an international consensus
-
5:34
st. gallen consensus highlights: ovarian suppression, oligometastatic disease and radiotherapy
-
0:35
duration of endocrine therapy in early breast cancer
-
1:54
hot topics at st gallen bcc
-
16:13
systemic therapy at the st gallen consensus: multi-gene testing, ki67, and oligometastatic disease
-
1:45
key topics at st. gallen 2021
-
4:47
breast reconstruction and radiation therapy consensus from airo
-
2:11
breast surgery - where do we go?
-
1:49
early breast cancer: do we need chemotherapy in low genomic/high clinical risk (er /her2-)?
-
0:28
patient advocates at st. gallen 2021
-
1:08
st gallen 2023: de-escalation, personalized treatment & adjuvant io following neoadjuvant io
-
0:28
controversies in the treatment of the axilla
-
24:08
a. coates: the evolution of the st. gallen consensus http://bcc14.oncoletter.ch
-
2:19
5-year dmfs outcomes in the nbreast ii trial